New Target Update: Preparing for the Next in Synthetic Opioid Trends, Nitazenes  

MX908 adds a new synthetic opioid, nitazines, to its drug target list, aiding responders against evolving threats.

One Pill Can Kill: Current and Emerging Drug Threats

908 Devices equips first responders with tools to identify dangerous drugs, a crucial need given the surge in fentanyl-laced counterfeit pills.

One Pill Can Kill: MX908 and Counterfeit Pills

The DEA has issued a public safety alert warning against a sharp increase in counterfeit pill overdoses in the US. The MX908 excels at identifying such pills.

The Impact and Rising Danger of the Opioid Epidemic

The opioid epidemic’s current wave is fueled by potent synthetic opioids that are significantly increasing in danger. Learn how the MX908 addresses this crisis.

New Update: Threat-Focused Targets

An MX908 target list update has been released, adding critical targets for evolving drug, explosive, and chemical threats.

See the Unseen: Trace Chemical Detection in the Field

The MX908 provides instant trace chemical detection of narcotics in the field, enabling stronger evidence for investigations & warrants.

Beyond Bulk: Trace Detection of Fentanyl in the Field

The MX908 keeps first responders safe by rapidly identifying unknown substance traces, including fentanyl and synthetic opioids.

The Road to IPO

Follow 908 Devices’ inspiring journey to becoming a public company. Learn about the company’s mission to revolutionize mass spectrometry.

Our 908th Customer

908 Devices welcomes the 908th customer. Learn how MX908 is enhancing their capabilities in hazardous material detection and response.

Q&A with John Kenneweg – The Changing Threat Landscape

The evolving threat landscape for CBRNE, narcotics, and explosives drives demand for advanced technology for first responders.

R.I.P Delayed Gratification

Explore the growing demand for instant access to data and how 908 Devices is transforming mass spectrometry with on-demand, portable solutions.

email

Subscribe to Our Communications